NAD+ attenuates cardiac injury after myocardial infarction in diabetic mice through regulating alternative splicing of VEGF in macrophages.
Jiao L, Gong M, Yang X, Li M, Shao Y, Wang Y, Li H, Yu Q, Sun L, Xuan L, Huang J, Wang Y, Liu D, Qu Y, Lan X, Zhang Y, Zhang X, Sun H, Zhang Y, Zhang Y, Yang B.
Jiao L, et al. Among authors: huang j.
Vascul Pharmacol. 2022 Dec;147:107126. doi: 10.1016/j.vph.2022.107126. Epub 2022 Nov 6.
Vascul Pharmacol. 2022.
PMID: 36351515